Rituximab prophylaxis to prevent thrombotic thrombocytopenic purpura relapse: outcome and evaluation of dosing regimens

Acute antibody-mediated thrombotic thrombocytopenic purpura (TTP) is a thrombotic microangiopathy with high morbidity and mortality. Rituximab is highly effective as prophylaxis in patients at risk of acute TTP relapse, but the ideal dosing regimen is unknown. A multicenter retrospective cohort stud...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Westwood, John-Paul, Thomas, Mari, Alwan, Ferras, McDonald, Vickie, Benjamin, Sylvia, Lester, William A., Lowe, Gillian C., Dutt, Tina, Hill, Quentin A., Scully, Marie
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2017
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5728327/
https://ncbi.nlm.nih.gov/pubmed/29296757
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2017008268
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados